Adverse events associated with medical cannabis reported within a centralized call center
Abstract Introduction: The use of medical cannabis products is expanding, yet real-world data on associated adverse events (AEs) remain limited.…
Abstract Introduction: The use of medical cannabis products is expanding, yet real-world data on associated adverse events (AEs) remain limited.…
Abstract Chronic use of high-potency cannabinoids has been consistently associated with an increased risk of psychosis, particularly with early onset,…
Abstract Endometriosis is a chronic, inflammatory, and multifactorial disease characterized by the presence of endometrial tissue outside the uterine cavity,…
Abstract Background: Cannabis use is on the rise yet the systematic molecular impact of key cannabinoid components on various tissues…
Abstract Introduction: This study aimed to evaluate the utilization of medical cannabis in a pediatric population and compare short-term persistence…
Abstract Aims: Progressive legalization of medical and recreational cannabis markets at the state-level has led to rapid growth of medical…
Abstract Cannabinoid use and misuse has been rising since 2011, and the development of new cannabinoid derivatives, partially due to…
Abstract Medicinal cannabis use is increasing worldwide, yet its impacts on driving safety in frequent users are not clearly understood.…
Abstract Chronic pain affects over 20% of the global population and contributes to the vast burden of psychiatric illness. While…
Abstract The use of paclitaxel as a chemotherapeutic drug is limited by the development of dose-dependent paclitaxel-induced neuropathic pain (PINP).…